{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:00:38Z","timestamp":1784732438831,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002649","name":"Yeungnam University","doi-asserted-by":"publisher","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"10.13039\/501100002649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p><jats:italic>Boswellia serrata<\/jats:italic> gum is a natural product that showed beneficial effects on neurodegenerative diseases in recent studies. In this study, we investigated the effects of <jats:italic>Boswellia serrata<\/jats:italic> resin on rotenone-induced dopaminergic neurotoxicity. Firstly, we attempted to see if the resin can induce AMP-activated protein kinase (AMPK) signaling pathway which has been known to have broad neuroprotective effects. Boswellia increased AMPK phosphorylation and reduced phosphorylation of mammalian target of rapamycin (p-mTOR) and \u03b1-synuclein (p-\u03b1-synuclein) in the striatum while increased the expression level of Beclin1, a marker for autophagy and brain-derived neurotrophic factor. Next, we examined the neuroprotective effects of the Boswellia extract in the rotenone-injected mice. The results showed that Boswellia evidently attenuated the loss of the nigrostriatal dopaminergic neurons and microglial activation caused by rotenone. Moreover, Boswellia ameliorated rotenone-induced decrease in the striatal dopamine and impairment in motor function. Accumulation of \u03b1-synuclein meditated by rotenone was significantly ameliorated by Boswellia. Also, we showed that \u03b2-boswellic acid, the active constituents of\u00a0<jats:italic>Boswellia serrata\u00a0<\/jats:italic>gum, induced AMPK phosphorylation and attenuated \u03b1-synuclein phosphorylation in SHSY5 cells. These results suggest that Boswellia protected the dopaminergic neurons from rotenone neurotoxicity via activation of the AMPK pathway which might be associated with attenuation of \u03b1-synuclein aggregation and neuroinflammation. Further investigations are warranted to identify specific molecules in Boswellia which are responsible for the neuroprotection.<\/jats:p>","DOI":"10.1007\/s12035-022-02943-y","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T21:02:36Z","timestamp":1657314156000},"page":"5874-5890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Methanolic Extract of Boswellia serrata Gum Protects the Nigral Dopaminergic Neurons from Rotenone-Induced Neurotoxicity"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-1096","authenticated-orcid":false,"given":"Sina","family":"Shadfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shristi","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Bohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geumjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Sadigh-Eteghad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyukjae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"S3","key":"2943_CR1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10140","volume":"17","author":"H Bergman","year":"2002","unstructured":"Bergman H, Deuschl G (2002) Pathophysiology of Parkinson\u2019s disease: from clinical neurology to basic neuroscience and back. Mov Disord 17(S3):S28\u2013S40","journal-title":"Mov Disord"},{"issue":"6","key":"2943_CR2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103(6):1661\u20131668","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2943_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-1","volume":"2","author":"RM Gir\u00e1ldez-P\u00e9rez","year":"2014","unstructured":"Gir\u00e1ldez-P\u00e9rez RM et al (2014) Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol Commun 2(1):1","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"2943_CR4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K et al (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates. Neuropathology 27(5):494\u2013506","journal-title":"Neuropathology"},{"issue":"6","key":"2943_CR5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"W Gibb","year":"1988","unstructured":"Gibb W, Lees A (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51(6):745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6645","key":"2943_CR6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG et al (1997) \u03b1-Synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"1","key":"2943_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L","volume":"14","author":"LI Golbe","year":"1999","unstructured":"Golbe LI (1999) Alpha-synuclein and Parkinson\u2019s disease. Mov Disord 14(1):6\u20139","journal-title":"Mov Disord"},{"issue":"13\u201314","key":"2943_CR8","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/PL00000671","volume":"57","author":"C L\u00fccking","year":"2000","unstructured":"L\u00fccking C, Brice A (2000) Alpha-synuclein and Parkinson\u2019s disease. Cell Mol Life Sci CMLS 57(13\u201314):1894\u20131908","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"2","key":"2943_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108","journal-title":"Nat Genet"},{"issue":"5321","key":"2943_CR10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"6","key":"2943_CR11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA et al (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63(6):743\u2013750","journal-title":"Ann Neurol"},{"issue":"11","key":"2943_CR12","first-page":"3257","volume":"119","author":"L Chen","year":"2009","unstructured":"Chen L et al (2009) Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Investig 119(11):3257\u20133265","journal-title":"J Clin Investig"},{"issue":"2","key":"2943_CR13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H et al (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160\u2013164","journal-title":"Nat Cell Biol"},{"issue":"10","key":"2943_CR14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","volume":"5","author":"AH Schapira","year":"2006","unstructured":"Schapira AH et al (2006) Novel pharmacological targets for the treatment of Parkinson\u2019s disease. Nat Rev Drug Discovery 5(10):845\u2013854","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"2943_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00019052-200208000-00011","volume":"15","author":"R Tintner","year":"2002","unstructured":"Tintner R, Jankovic J (2002) Treatment options for Parkinson\u2019s disease. Curr Opin Neurol 15(4):467\u2013476","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"2943_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","volume":"25","author":"J Jankovic","year":"2012","unstructured":"Jankovic J, Poewe W (2012) Therapies in Parkinson\u2019s disease. Curr Opin Neurol 25(4):433\u2013447","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"2943_CR17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/11591320-000000000-00000","volume":"28","author":"C Henchcliffe","year":"2011","unstructured":"Henchcliffe C, Severt WL (2011) Disease modification in Parkinson\u2019s disease. Drugs Aging 28(8):605\u2013615","journal-title":"Drugs Aging"},{"issue":"11","key":"2943_CR18","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/jnnp.2004.035980","volume":"76","author":"A Schapira","year":"2005","unstructured":"Schapira A (2005) Present and future drug treatment for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 76(11):1472\u20131478","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2943_CR19","unstructured":"Leung AY, Foster S (1996) Encyclopedia of common natural ingredients used in food, drugs, and cosmetics, 2nd edn.\u00a0John Wiley & Sons,\u00a0p 332\u2013334"},{"issue":"10","key":"2943_CR20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1211\/jpp\/61.10.0003","volume":"61","author":"A Moussaieff","year":"2009","unstructured":"Moussaieff A, Mechoulam R (2009) Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol 61(10):1281\u20131293","journal-title":"J Pharm Pharmacol"},{"key":"2943_CR21","doi-asserted-by":"publisher","unstructured":"Ernst E (2008) Frankincense: systematic review.\u00a0BMJ 337:a2813. https:\/\/doi.org\/10.1136\/bmj.a2813","DOI":"10.1136\/bmj.a2813"},{"issue":"1","key":"2943_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1078\/094471103321648593","volume":"10","author":"N Kimmatkar","year":"2003","unstructured":"Kimmatkar N et al (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee\u2013a randomized double blind placebo controlled trial. Phytomedicine 10(1):3\u20137","journal-title":"Phytomedicine"},{"key":"2943_CR23","doi-asserted-by":"crossref","unstructured":"Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, M\u00fcller S, Senninger N, Russell J et al (2006) Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis.\u00a0Am J Physiol Gastrointest Liver Physiol\u00a0290(6):G1131\u2013G1137","DOI":"10.1152\/ajpgi.00562.2005"},{"issue":"3","key":"2943_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0250-474X.93507","volume":"73","author":"MZ Siddiqui","year":"2011","unstructured":"Siddiqui MZ (2011) Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci 73(3):255\u2013261. https:\/\/doi.org\/10.4103\/0250-474X.93507","journal-title":"Indian J Pharm Sci"},{"key":"2943_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1687-4293.132766","volume":"8","author":"N Yassin","year":"2013","unstructured":"Yassin N et al (2013) Effect of Boswellia serrata on Alzheimer\u2019s disease induced in rats. J Arab Soc Med Res 8:1\u201311","journal-title":"J Arab Soc Med Res"},{"issue":"3","key":"2943_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10072-010-0220-x","volume":"31","author":"O Karima","year":"2010","unstructured":"Karima O et al (2010) The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study). Neurol Sci 31(3):315\u2013320","journal-title":"Neurol Sci"},{"issue":"4","key":"2943_CR27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.foodchem.2004.08.033","volume":"92","author":"A Assimopoulou","year":"2005","unstructured":"Assimopoulou A, Zlatanos S, Papageorgiou V (2005) Antioxidant activity of natural resins and bioactive triterpenes in oil substrates. Food Chem 92(4):721\u2013727","journal-title":"Food Chem"},{"issue":"4","key":"2943_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/2225-4110.119723","volume":"3","author":"R Hamidpour","year":"2013","unstructured":"Hamidpour R et al (2013) Frankincense (\u4e73\u9999 R\u01d4 Xi\u0101ng; Boswellia Species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med 3(4):221","journal-title":"J Tradit Complement Med"},{"issue":"1","key":"2943_CR29","first-page":"16","volume":"3","author":"S Kazmi","year":"2011","unstructured":"Kazmi S et al (2011) The effects of Boswellia resin extract on dopaminergic cell line, SK-N-SH, against MPP+-induced neurotoxicity. Basic Clin Neurosci 3(1):16\u201321","journal-title":"Basic Clin Neurosci"},{"issue":"1","key":"2943_CR30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12035-016-0342-0","volume":"55","author":"S Shadfar","year":"2018","unstructured":"Shadfar S et al (2018) Neuroprotective effects of antidepressants via upregulation of neurotrophic factors in the MPTP model of Parkinson\u2019s disease. Mol Neurobiol 55(1):554\u2013566","journal-title":"Mol Neurobiol"},{"issue":"7","key":"2943_CR31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676\u2013682","journal-title":"Nat Methods"},{"key":"2943_CR32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila N et al (2017) Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 125:396\u2013407","journal-title":"Neuropharmacology"},{"key":"2943_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuint.2016.12.002","volume":"102","author":"YY Jung","year":"2017","unstructured":"Jung YY et al (2017) Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32\u03b2 transgenic mice. Neurochem Int 102:79\u201388","journal-title":"Neurochem Int"},{"key":"2943_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"M Ekor","year":"2014","unstructured":"Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharm 4:177. https:\/\/doi.org\/10.3389\/fphar.2013.00177","journal-title":"Front Pharm"},{"issue":"7","key":"2943_CR35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1139\/cjpp-2016-0158","volume":"95","author":"AM Ameen","year":"2017","unstructured":"Ameen AM et al (2017) Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats. Can J Physiol Pharmacol 95(7):819\u2013829","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"2943_CR36","first-page":"129","volume":"39","author":"P Ren","year":"2018","unstructured":"Ren P et al (2018) Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK\/mTOR pathway in breast cancer. Oncol Rep 39(1):129\u2013137","journal-title":"Oncol Rep"},{"issue":"2","key":"2943_CR37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214\u2013226","journal-title":"Mol Cell"},{"issue":"5","key":"2943_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115(5):577\u2013590","journal-title":"Cell"},{"issue":"1","key":"2943_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-017-0220-x","volume":"12","author":"W Bobela","year":"2017","unstructured":"Bobela W et al (2017) Modulating the catalytic activity of AMPK has neuroprotective effects against \u03b1-synuclein toxicity. Mol Neurodegener 12(1):80","journal-title":"Mol Neurodegener"},{"key":"2943_CR40","doi-asserted-by":"crossref","first-page":"105560","DOI":"10.1016\/j.nbd.2021.105560","volume":"161","author":"L Hang","year":"2021","unstructured":"Hang L et al (2021) Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson\u2019s disease-associated phenotypes in vivo. Neurobiol Dis 161:105560","journal-title":"Neurobiol Dis"},{"issue":"2","key":"2943_CR41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J et al (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13(2):132\u2013141","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2943_CR42","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22605","volume":"34","author":"F Yarmohammadi","year":"2020","unstructured":"Yarmohammadi F et al (2020) The protective effect of natural compounds against rotenone-induced neurotoxicity. J Biochem Mol Toxicol 34(12):e22605","journal-title":"J Biochem Mol Toxicol"},{"issue":"18","key":"2943_CR43","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/onc.2012.252","volume":"32","author":"C Gong","year":"2013","unstructured":"Gong C et al (2013) Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like\/progenitor cells. Oncogene 32(18):2261-72,2272e.1\u201311","journal-title":"Oncogene"},{"key":"2943_CR44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2022.03.001","volume":"345","author":"Y Esmaeili","year":"2022","unstructured":"Esmaeili Y et al (2022) Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment. J Control Release 345:147\u2013175","journal-title":"J Control Release"},{"issue":"3","key":"2943_CR45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/cr.2009.129","volume":"20","author":"S Ghavami","year":"2010","unstructured":"Ghavami S et al (2010) S100A8\/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 20(3):314\u2013331","journal-title":"Cell Res"},{"key":"2943_CR46","doi-asserted-by":"crossref","first-page":"33146","DOI":"10.1038\/srep33146","volume":"6","author":"AS Pathania","year":"2016","unstructured":"Pathania AS et al (2016) Interplay between cell cycle and autophagy induced by boswellic acid analog. Sci Rep 6:33146","journal-title":"Sci Rep"},{"key":"2943_CR47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcell.2019.00170","volume":"7","author":"C Li","year":"2019","unstructured":"Li C et al (2019) Proteasome inhibition activates autophagy-lysosome pathway associated with TFEB dephosphorylation and nuclear translocation. Front Cell Devel Biol 7:170","journal-title":"Front Cell Devel Biol"},{"issue":"27","key":"2943_CR48","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb JL et al (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278(27):25009\u201325013","journal-title":"J Biol Chem"},{"issue":"2","key":"2943_CR49","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","volume":"5","author":"L Crews","year":"2010","unstructured":"Crews L et al (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE 5(2):e9313","journal-title":"PLoS ONE"},{"issue":"19","key":"2943_CR50","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","volume":"110","author":"M Decressac","year":"2013","unstructured":"Decressac M et al (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity. Proc Natl Acad Sci U S A 110(19):E1817\u2013E1826","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6315","key":"2943_CR51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","volume":"350","author":"C Hyman","year":"1991","unstructured":"Hyman C et al (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350(6315):230\u2013232","journal-title":"Nature"},{"issue":"1\u20132","key":"2943_CR52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0169-328X(99)00015-7","volume":"66","author":"L Feng","year":"1999","unstructured":"Feng L et al (1999) Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 66(1\u20132):62\u201370","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"2943_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","volume":"270","author":"M Mogi","year":"1999","unstructured":"Mogi M et al (1999) Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease. Neurosci Lett 270(1):45\u201348","journal-title":"Neurosci Lett"},{"issue":"3","key":"2943_CR54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH et al (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nat Med 15(3):331\u2013337","journal-title":"Nat Med"},{"issue":"12","key":"2943_CR55","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1523\/JNEUROSCI.15-12-07810.1995","volume":"15","author":"M Levivier","year":"1995","unstructured":"Levivier M et al (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson\u2019s disease. J Neurosci 15(12):7810\u20137820","journal-title":"J Neurosci"},{"key":"2943_CR56","doi-asserted-by":"crossref","first-page":"114193","DOI":"10.1016\/j.bcp.2020.114193","volume":"180","author":"N Katila","year":"2020","unstructured":"Katila N et al (2020) Activation of AMPK\/aPKC\u03b6\/CREB pathway by metformin is associated with upregulation of GDNF and dopamine. Biochem Pharmacol 180:114193","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2943_CR57","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3906\/sag-1503-43","volume":"46","author":"M Khalaj-Kondori","year":"2016","unstructured":"Khalaj-Kondori M et al (2016) Boswellia serrata gum resin aqueous extract upregulatesBDNF but not CREB expression in adult male rat hippocampus. Turkish J Med Sci 46(5):1573\u20131578","journal-title":"Turkish J Med Sci"},{"issue":"12","key":"2943_CR58","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"issue":"1","key":"2943_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","volume":"179","author":"TB Sherer","year":"2003","unstructured":"Sherer TB et al (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179(1):9\u201316","journal-title":"Exp Neurol"},{"issue":"3","key":"2943_CR60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5607\/en20014","volume":"29","author":"WH Shin","year":"2020","unstructured":"Shin WH, Chung KC (2020) Death-associated protein kinase 1 phosphorylates \u03b1-synuclein at Ser129 and exacerbates rotenone-induced toxic aggregation of \u03b1-synuclein in dopaminergic SH-SY5Y cells. Exp Neurobiol 29(3):207\u2013218","journal-title":"Exp Neurobiol"},{"issue":"5","key":"2943_CR61","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/ijms23052484","volume":"23","author":"S Shadfar","year":"2022","unstructured":"Shadfar S, Brocardo M, Atkin JD (2022) The complex mechanisms by which neurons die following DNA damage in neurodegenerative diseases. Int J Mol Sci 23(5):2484","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2943_CR62","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41419-018-0848-7","volume":"9","author":"C Milanese","year":"2018","unstructured":"Milanese C et al (2018) Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson\u2019s disease. Cell Death Dis 9(8):818","journal-title":"Cell Death Dis"}],"updated-by":[{"DOI":"10.1007\/s12035-024-04481-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02943-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:16:31Z","timestamp":1726766191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02943-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2943"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02943-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-024-04481-1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-024-04481-1","URL":"https:\/\/doi.org\/10.1007\/s12035-024-04481-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the experimental procedures were performed in line with the principles and guidelines of the institutional animal care and use committee of Yeungnam University for the humane care and use of laboratory animals (approval number: 2017\u2013028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}